Market Research Reports and Industry Reports

Batten Disease - Pipeline Review, H2 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Summary
 
 Global Markets Direct’s, ‘Batten disease - Pipeline Review, H2 2015’, provides an overview of the Batten disease’s therapeutic pipeline.
 
 This report provides comprehensive information on the therapeutic development for Batten disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Batten disease and special features on late-stage and discontinued projects.
 
 Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
 
 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
 
 Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - The report provides a snapshot of the global therapeutic landscape of Batten disease
 - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
 - The report reviews key players involved in the therapeutics development for Batten disease and enlists all their major and minor projects
 - The report summarizes all the dormant and discontinued pipeline projects
 - A review of the Batten disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
 - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
 - A detailed assessment of monotherapy and combination therapy pipeline projects
 - Coverage of the Batten disease pipeline on the basis of target, MoA, route of administration and molecule type
 - Latest news and deals relating related to pipeline products
 
 Reasons to buy
 
 - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
 - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 - Develop strategic initiatives by understanding the focus areas of leading companies
 - Identify and understand important and diverse types of therapeutics under development for Batten disease
 - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
 - Devise corrective measures for pipeline projects by understanding Batten disease pipeline depth and focus of Indication therapeutics
 - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 Table of Contents 2
 List of Tables 4
 List of Figures 5
 Introduction 6
 Global Markets Direct Report Coverage 6
 Batten Disease Overview 7
 Therapeutics Development 8
 Pipeline Products for Batten Disease - Overview 8
 Pipeline Products for Batten Disease - Comparative Analysis 9
 Batten Disease - Therapeutics under Development by Companies 10
 Batten Disease - Therapeutics under Investigation by Universities/Institutes 11
 Batten Disease - Pipeline Products Glance 12
 Clinical Stage Products 12
 Early Stage Products 13
 Unknown Stage Products 14
 Batten Disease - Products under Development by Companies 15
 Batten Disease - Products under Investigation by Universities/Institutes 16
 Batten Disease - Companies Involved in Therapeutics Development 17
 Abeona Therapeutics, Inc. 17
 BioMarin Pharmaceutical Inc. 18
 CereSpir Incorporated 19
 Xonovo Inc 20
 Batten Disease - Therapeutics Assessment 21
 Assessment by Monotherapy Products 21
 Assessment by Target 22
 Assessment by Mechanism of Action 24
 Assessment by Route of Administration 26
 Assessment by Molecule Type 28
 Drug Profiles 30
 ABO-201 - Drug Profile 30
 Product Description 30
 Mechanism of Action 30
 R&D Progress 30
 cerliponase alfa - Drug Profile 31
 Product Description 31
 Mechanism of Action 31
 R&D Progress 31
 CSP-1103 - Drug Profile 32
 Product Description 32
 Mechanism of Action 32
 R&D Progress 32
 Gene Therapy to Activate Palmitoyl Protein Thioesterase 1 for Batten Disease - Drug Profile 34
 Product Description 34
 Mechanism of Action 34
 R&D Progress 34
 Gene Therapy to Activate Tripeptidyl Peptidase 1 for Batten Disease - Drug Profile 35
 Product Description 35
 Mechanism of Action 35
 R&D Progress 35
 INI-0602 - Drug Profile 36
 Product Description 36
 Mechanism of Action 36
 R&D Progress 36
 MP-101 - Drug Profile 37
 Product Description 37
 Mechanism of Action 37
 R&D Progress 37
 Small Molecules to Inhibit CDC42 for Batten Disease - Drug Profile 38
 Product Description 38
 Mechanism of Action 38
 R&D Progress 38
 SNB-2401 - Drug Profile 39
 Product Description 39
 Mechanism of Action 39
 R&D Progress 39
 SNB-4050 - Drug Profile 40
 Product Description 40
 Mechanism of Action 40
 R&D Progress 40
 XN-001 - Drug Profile 41
 Product Description 41
 Mechanism of Action 41
 R&D Progress 41
 Batten Disease - Recent Pipeline Updates 42
 Batten Disease - Dormant Projects 45
 Batten Disease - Discontinued Products 46
 Batten Disease - Product Development Milestones 47
 Featured News & Press Releases 47
 Jan 12, 2015: BioMarin Provides Preliminary Data From Ongoing Phase 1/2 Pivotal Study of BMN 190 for Treatment of CLN2 Disorder, a Form of Batten Disease 47
 Sep 23, 2013: BioMarin Doses First Patient in Phase 1/2 Trial With BMN 190 for the Treatment of Neuronal Ceroid Lipofuscinosis Type 2, a Form of Batten Disease 48
 Apr 01, 2013: BioMarin Pharma Submits CTA For BMN-190 For Batten Disease 48
 Mar 15, 2012: Combination treatment in mice shows promise for fatal neurological disorder in kids 49
 Appendix 51
 Methodology 51
 Coverage 51
 Secondary Research 51
 Primary Research 51
 Expert Panel Validation 51
 Contact Us 51
 Disclaimer 52


List Of Tables

 Number of Products under Development for Batten Disease, H2 2015 8
 Number of Products under Development for Batten Disease - Comparative Analysis, H2 2015 9
 Number of Products under Development by Companies, H2 2015 10
 Number of Products under Investigation by Universities/Institutes, H2 2015 11
 Comparative Analysis by Clinical Stage Development, H2 2015 12
 Comparative Analysis by Early Stage Development, H2 2015 13
 Comparative Analysis by Unknown Stage Development, H2 2015 14
 Products under Development by Companies, H2 2015 15
 Products under Investigation by Universities/Institutes, H2 2015 16
 Batten Disease - Pipeline by Abeona Therapeutics, Inc. , H2 2015 17
 Batten Disease - Pipeline by BioMarin Pharmaceutical Inc., H2 2015 18
 Batten Disease - Pipeline by CereSpir Incorporated, H2 2015 19
 Batten Disease - Pipeline by Xonovo Inc, H2 2015 20
 Assessment by Monotherapy Products, H2 2015 21
 Number of Products by Stage and Target, H2 2015 23
 Number of Products by Stage and Mechanism of Action, H2 2015 25
 Number of Products by Stage and Route of Administration, H2 2015 27
 Number of Products by Stage and Molecule Type, H2 2015 29
 Batten Disease Therapeutics - Recent Pipeline Updates, H2 2015 42
 Batten Disease - Dormant Projects, H2 2015 45
 Batten Disease - Discontinued Products, H2 2015 46


List Of Figures

 Number of Products under Development for Batten Disease, H2 2015 8
 Number of Products under Development for Batten Disease - Comparative Analysis, H2 2015 9
 Number of Products under Development by Companies, H2 2015 10
 Number of Products under Investigation by Universities/Institutes, H2 2015 11
 Comparative Analysis by Clinical Stage Development, H2 2015 12
 Comparative Analysis by Early Stage Products, H2 2015 13
 Assessment by Monotherapy Products, H2 2015 21
 Number of Products by Top 10 Targets, H2 2015 22
 Number of Products by Stage and Top 10 Targets, H2 2015 22
 Number of Products by Top 10 Mechanism of Actions, H2 2015 24
 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 24
 Number of Products by Top 10 Routes of Administration, H2 2015 26
 Number of Products by Stage and Top 10 Routes of Administration, H2 2015 26
 Number of Products by Top 10 Molecule Types, H2 2015 28
 Number of Products by Stage and Top 10 Molecule Types, H2 2015 28


Global Ceiling Lighting & Battens Sales Market Report 2016

Notes:Sales, means the sales volume of Ceiling Lighting & BattensRevenue, means the sales value of Ceiling Lighting & BattensThis report studies sales (consumption) of Ceiling Lighting & Battens in Global

USD 4000View Report

URA – Mountbatten Road Office Development – Singapore - Construction Project Profile

Synopsis URA Mountbatten Road Office Development Singapore contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives

USD 75View Report

China Ceiling Lighting & Battens Market Research Report 2016

Notes:Sales, means the sales volume of Ceiling Lighting & BattensRevenue, means the sales value of Ceiling Lighting & BattensThis report studies Ceiling Lighting & Battens in China market, focuses on

USD 3200View Report

Parkinson Disease - Market Insights, Epidemiology and Market Forecast – 2023 - United States

DelveInsights Parkinson Disease - Market Insights, Epidemiology and Market Forecast 2023 - United States Reports provides an overview of the disease and global market size of the Parkinson Disease

USD 2450View Report

Parkinson Disease - Market Insights, Epidemiology and Market Forecast – 2023 - Japan

DelveInsights Parkinson Disease - Market Insights, Epidemiology and Market Forecast 2023 - Japan Reports provides an overview of the disease and global market size of the Parkinson Disease for

USD 1750View Report

Parkinson Disease - Market Insights, Epidemiology and Market Forecast – 2023 - EU5

DelveInsights Parkinson Disease - Market Insights, Epidemiology and Market Forecast 2023 - EU5 Reports provides an overview of the disease and global market size of the Parkinson Disease for

USD 2450View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 2000
  • Site Licence    $ 4000
  • Enterprise Wide Licence    $ 6000
$ 2000

Reports Details

Published Date : Jul 2015
No. of Pages :52
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

,
 

We Accept

payment